Binnaz K Staley

Title: Binnaz K Staley: Innovator in Immunotherapy

Introduction

Binnaz K Staley is a prominent inventor based in San Carlos, CA (US). She has made significant contributions to the field of immunotherapy, particularly through her innovative patents. With a total of 2 patents, her work focuses on enhancing the capabilities of immune cells.

Latest Patents

Staley's latest patents include "Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof." This application provides immune cells, such as T cells, that comprise a chimeric antibody-T cell receptor (TCR) construct and a chimeric signaling receptor (CSR) construct. The caTCR includes an antigen-binding module that specifically binds to a target antigen and a T cell receptor module capable of recruiting TCR-associated signaling molecules. The CSR features a ligand-binding domain that binds to a target ligand and a co-stimulatory signaling domain that provides a stimulatory signal to the immune cell. Additionally, methods for making and using these cells are also provided.

Career Highlights

Binnaz K Staley is currently associated with Eureka Therapeutics, Inc., where she continues to advance her research and development efforts in immunotherapy. Her work has the potential to significantly impact the treatment of various diseases by harnessing the power of the immune system.

Collaborations

Staley collaborates with notable colleagues, including Hong Liu and Pengbo Zhang, who contribute to her research endeavors.

Conclusion

Binnaz K Staley is a trailblazer in the field of immunotherapy, with her innovative patents paving the way for new therapeutic approaches. Her contributions are vital to the ongoing advancements in immune cell technology.